The company led by Joaquin Duato launches a rebranding as it focuses on higher-risk prescription drugs and medical devices after shedding its consumer business.
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
Joaquin Duato early last year assumed the role of CEO after spearheading the growth of J&J’s pharmaceutical unit.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
New faces, new struggles, new celebrations in 'Welcome to Wrexham' season 2'Welcome to Wrexham' season 2 preview: new faces, new struggles and lots of reasons to rejoice.
Leer más »
New faces, new struggles, new celebrations in 'Welcome to Wrexham' season 2'Welcome to Wrexham' season 2 preview: new faces, new struggles and lots of reasons to rejoice.
Leer más »
Baseball: New Rules, New Stars, New SongsBaseball seemed to reinvent itself in 2023. There were new rules, new stars, and new songs, thanks to a new album from the Baseball Project.
Leer más »
Johnson & Johnson is getting rid of its script logo after more than 130 yearsJohnson & Johnson is signing off on a new logo, more than 130 years after creating the old one.
Leer más »
Johnson & Johnson is getting rid of its script logo after more than 130 yearsJohnson & Johnson is signing off on a new logo, more than 130 years after creating the old one.
Leer más »
Man, 15-year-old boy wanted in shooting of 18-year-old woman in northeast HoustonA man and teen are wanted in a shooting that left an 18-year-old woman injured on Sunday in northeast Houston, according to the Houston Police Department.
Leer más »